Radiation therapy treats roughly two-thirds of all cancer patients, yet healthy tissue has always absorbed collateral damage ...

"So, we are now colonizing that central space, and the bacterium is essentially ridding the body of the tumor." The post ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies ...

Pancreatic cancer is one of the most dangerous forms of cancer in the world. Doctors and scientists have struggled for many years to find effective treatments for it. Many patients are diagnosed at a ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Aricca Wallace had a tumor the size of a baby's head. She likely had less than a year to live. This cervical cancer clinical trial changed everything.

You may be reading this because you or someone you care about has nasal cavity or sinus cancer. Learning more can help you get ready to talk with your healthcare provider and understand the next steps ...

A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at ...

Cancer survivors visit the Fight Colorectal Cancer "United in Blue" flag installation on the National Mall to spotlight the ...